Comparative study on salivary distribution of fluoroquinolones in rats

Biological and Pharmaceutical Bulletin

Volumn 25, Issue 8, 2002, Pages 1084-1089

  Li, Q ^a,b   Naora, Kohji ^a   Hirano, Hidenari ^a   Okunishi, Hideki ^b   Iwamoto, Kikuo ^a  

^a SHIMANE UNIVERSITY HOSPITAL   (Japan)

^b SHIMANE UNIVERSITY   (Japan)

Author keywords

Fluoroquinolone; Lipophilicity; Salivary distribution

Indexed keywords

CIPROFLOXACIN; LOMEFLOXACIN; NORFLOXACIN; OCTANOL; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; WATER; ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CALCULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG BLOOD LEVEL; DRUG DIFFUSION; DRUG DISTRIBUTION; DRUG SALIVA LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTERMETHOD COMPARISON; LIPOPHILICITY; NONHUMAN; PAROTID GLAND; PARTITION COEFFICIENT; PH; QUANTITATIVE ANALYSIS; RAT; SALIVA ANALYSIS; STATISTICAL MODEL; SUBMANDIBULAR GLAND; THEORETICAL MODEL; ANIMAL; BLOOD; CHEMISTRY; COMPARATIVE STUDY; MALE; METABOLISM; SALIVA; SALIVARY GLAND; WISTAR RAT;

ANIMALS; ANTI-INFECTIVE AGENTS; FLUOROQUINOLONES; MALE; RATS; RATS, WISTAR; SALIVA; SALIVARY GLANDS;

EID: 0036690668     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.25.1084     Document Type: Article

References (35)

1. Danhof M., Breimer D. D., Clin. Pharmacokinet., 3, 39-57 (1978).
2. Miles M. V., Tennison M. B., Greenwood R. S., Benoit S. E., Thorn M. D., Messenheimer J. A., Ehle A. L., Ther. Drug Monit, 12, 501-510 (1992).
3. Schramm W., Annesley T. M., Siegel G. J., Sackellares J. C., Smith R. H., Ther. Drug Monit., 13, 452-460 (1991).
4. Siegel I. A., Ben-Aryeh H., Gozal D., Colin A. A., Szargel R., Laufer D., Ther. Drug Monit., 12, 460-464 (1990)
5. Neuman M., Clin. Pharmacokinet., 14, 96-121 (1988).
6. Wolfson J. S., Hooper D. C., Clin. Microbiol. Rev., 2, 378-424 (1989).
7. Shimada J., Nogita T., Ishibashi Y., Clin. Pharmacokinet., 25, 358-369 (1993).
8. Ohkubo T., Suno M., Kudo M., Uno T., Sugawara K., Ther. Drug Monit., 18, 598-603 (1996).
9. Furet Y. X., Deshusses J., Pechere J.-C., Antimicrob. Agents Chemother., 36, 2506-2511 (1992).
10. Haeckel R., Hänecke P., Eur. J. Clin. Chem. Clin. Biochem., 34, 171-191 (1996).
11. Watanabe J., Nakase Y., Urasaki Y., Hayashi Y., Iwamoto K., Ozeki S., J. Pharmacobio-Dyn., 4, 968-977 (1981).
12. Ding G., Naora K., Nagasako S., Hirano H., Iwamoto K., J. Pharmacol. Exp. Ther., 287, 31-36 (1998).
13. Katagiri Y., Naora K., Ichikawa N., Hayashibara M., Iwamoto K., Chem. Pharm. Bull., 37, 2858-2860 (1989).
14. Healy D. P., Schoenle J. R., Stotka J., Polk R. E., Antimicrob. Agents Chemother., 35, 660-664 (1991).
15. Wright D. H., Herman V. K., Konstantinides F. N., Rotsehafer J. C., J. Chromatogr. B, 709, 97-104 (1998).
16. Borner K., Borner E., Lode H., J. Chromatogr., 579, 285-289 (1992).
17. Jaehde U., Goto T., de Boer A. G., Breimer D. D., Eur. J. Pharm. Sci., 1, 49-55 (1993).
18. Ooie T., Suzuki H., Terasaki T., Sugiyama Y., J. Pharmacol. Exp. Ther., 278, 590-596 (1996).
19. Matin S. B., Wan S. H., Karam J. H., Clin. Pharmacol. Ther., 16, 1052-1058 (1974).
20. Vesell E. S., Passananti G. T., Glenwright P. A., Dvorchik B. H., Clin. Pharmacol. Ther., 18, 259-272 (1975).
21. Windle W. F., "Textbook of Histology," Fifth edition. McGraw-Hill Book Company. New York, 1976.
22. Jusko W. J., Milsap R. L., Ann. N. Y. Acad. Sci., 694, 36-47 (1993).
23. Liu W., Liu Q. F., Perkins R., Drusano G., Louie A., Madu A., Mian U., Mayers M., Miller M. H., Antimicrob. Agents Chemother., 42, 1417-1423 (1998).
24. Fitton A., Clin. Pharmacokinet., 22 (Suppl. 1), 1-11 (1992).
25. Nagata O., Yamada T., Yamaguchi T., Okezaki E., Terasaki T., Tsuji A., Chemotherapy, 36, 151-173 (1988).
26. Sörgel F., Jaehde U., Naber K., Stephan U., Clin. Pharmacokinet., 16 (Suppl. 1), 5-24 (1989).
27. Ichikawa N., Naora K., Iwamoto K., Biol. Pharm. Bull., 17, 152-155 (1994).
28. Kozjek F., Suturkova L. J., Antolic G., Grabnar I., Mrhar A., Biopharm. Drug Dispos., 20, 183-191 (1999).
29. Foote E. F., Halstenson C. E., Antimicrob. Agents Chemother., 42, 456-458 (1998).
30. Prieto J. G., Barrio J. P., Alvarez A. I., Gómez G., J. Pharm. Pharmacol., 40, 211-212 (1988).
31. Ooie T., Suzuki H., Terasaki T., Sugiyama Y., Pharm. Res., 13, 1065-1068 (1996).
32. Allen M. A., Wrenn J. M., Putney J. W., Jr., Borzelleca J. F., J. Pharmacol. Exp. Ther., 197, 408-413 (1976).
33. Borzelleca J. F., Cherrick H. M., J. Oral Ther. Pharmacol., 2, 180-187 (1965).
34. Dawes C. P., Kendall M. J., John V. A., Br. J. Clin. Pharmacol., 5, 217-221 (1978).
35. Ding G., Naora K., Hirano H., Iwamoto K., Inotsume N., Chin. Hosp. Pharm. J., 21, 26-29 (2001).